China SXT Pharmaceuticals Announces Termination Of $12M Additional Purchase Right In Registered Direct Offering
Share
Why It Matters
SXT Pharma canceled a plan to sell $12 million in extra stock to investors. When companies give up selling stock, watch if they have enough cash to keep running.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.